Ads
    Related paper
  1. Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of secondary prevention
  2. Correction of Dyslipidemia in Patients with Coronary Heart Disease Combined with Nonalcoholic Fatty Liver Disease
  3. The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
  4. The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
  5. Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension
  6. Endogenous Intoxication Syndrome in Patients with Diabetes Mellitus in Combination with Nonalcoholic Fatty Liver Disease
  7. Parameters of Carbohydrate Metabolism and Expression of Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease and Hypertensive Depending on Lipid Parameters
  8. Association of serum uric acid level and body mass index between non alcoholic fatty liver disease patients and healthy volunteers
  9. PECULIARITIES OF THE VITAMIN D DEFICIENCY AND ITS INFLUENCE ON LIPID EXCHANGE INDICATORS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH OSTEOARTHROSIS
  10. Diabetes, Heart Disease, Fatty Liver, Blood Groups And COVID-19 Disease: A Brief Review of Evidence |Biomedgrid